NextPlat (NXPL) Interest Coverage Ratio Growth (1y) (2016 - 2025)
Powered by 
Analysis
NextPlat (NXPL) Interest Coverage Ratio Growth (1y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -97.39% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 85.68% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 95.71% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 649.91% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -11.17% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 12,688.80% |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -80.59% |
| Sep 30, 2025 | 60.93% |
| Jun 30, 2025 | 78.74% |
| Mar 31, 2025 | -31.99% |
| Dec 31, 2024 | 81.73% |
| Sep 30, 2024 | -381.02% |
| Jun 30, 2024 | 14.53% |
| Mar 31, 2024 | 64.57% |
| Dec 31, 2023 | -106.09% |
| Sep 30, 2023 | 69.54% |
| Jun 30, 2023 | -61.09% |
| Mar 31, 2023 | 3.79% |
| Dec 31, 2022 | 70.04% |
| Sep 30, 2022 | 73.54% |
| Jun 30, 2022 | -71,243.68% |
| Mar 31, 2022 | -44,728.45% |
| Dec 31, 2021 | -71,730.19% |
| Sep 30, 2021 | -126,723.33% |
| Jun 30, 2021 | 79.92% |
| Mar 31, 2021 | 72.61% |